Influence of opioid choice on mechanical ventilation duration and ICU length of stay

Minerva Anestesiologica

Volumn 78, Issue 1, 2012, Pages 46-53

  Futier, E ^a   Chanques, G ^b   Cayot Constantin, S ^a   Vernis, L ^a   Barres, A ^a   Guerin, R ^a   Chartier, C ^a   Perbet, S ^a   Petit, A ^a   Jabaudon, M ^a   Bazin, J E ^a   Constantin, J M ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Analgesia; Conscious sedation; Intensive care unit; Remifentanil; Respiration, artificial

Indexed keywords

HYPNOTIC AGENT; MIDAZOLAM; PROPOFOL; REMIFENTANIL; SUFENTANIL;

ADJUVANT THERAPY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG CHOICE; DRUG COST; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; NURSE PATIENT RATIO; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PROGNOSIS; PROSPECTIVE STUDY; RAMSAY SCALE; RATING SCALE; SEDATION; VENTILATED PATIENT;

ADULT; AGED; ANALGESICS, OPIOID; CONSCIOUS SEDATION; DATA COLLECTION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; NURSES; PIPERIDINES; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SUFENTANIL; VENTILATOR WEANING;

EID: 84855841551     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Constantin JM, Chanques G, De Jonghe B, Sanchez P, Mantz J, Payen JF et al. [Current use of sedation and analgesia: 218 resuscitations in France services practices survey]. Ann Fr Anesth Reanim 2010;29:339-46.
2. Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007;106:687-95; quiz 891-2.
3. Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L et al. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005;128:496-506.
4. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114:541-8.
5. Strom T, Toft P. Time to wake up the patients in the ICU: a crazy idea or common sense? Minerva Anestesiol 2010;77:59-63.
6. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999;27:2609-15.
7. De Jonghe B, Bastuji-Garin S, Fangio P, Lacherade JC, Jabot J, Appere-De-Vecchi C et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med 2005;33:120-7.
8. Quenot JP, Ladoire S, Devoucoux F, Doise JM, Cailliod R, Cunin N et al. Effect of a nurse-implemented sedation pro tocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007 [Epub ahead of print].
9. Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault PF et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 2006;34:1691-9.
10. Chanques G, Payen JF, Mercier G, de Lattre S, Viel E, Jung B et al. Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale. Intensive Care Med 2009;35:2060-7.
11. Mirski MA, Hemstreet MK. Critical care sedation for neuroscience patients. J Neurol Sci 2007;261:16-34.
12. Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010;375:475-80.
13. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]. Crit Care 2005;9:R200-10.
14. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care 2006;10:R91.
15. Park G, Lane M, Rogers S, Bassett P. A comparison of hypnotic and analgesic based sedation in a general intensive care unit. Br J Anaesth 2007;98:76-82.
16. Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B et al. Safety and efficacy of analgesiabased sedation with remifentanil versus standard hypnoticbased regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004;8:R268-80.
17. Rozendaal FW, Spronk PE, Snellen FF, Schoen A, van Zanten AR, Foudraine NA et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009;35:291-8.
18. Tan JA, Ho KM. Use of remifentanil as a sedative agent in critically ill adult patients: a meta-analysis. Anaesthesia 2009;64:1342-52.
19. Ho KM, Ng JY. The use of propofol for medium and longterm sedation in critically ill adult patients: a meta-analysis. Intensive care medicine 2008;34:1969-79.
20. Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST et al. Dexmedetomidine versus propofol/ midazolam for long-term sedation during mechanical ventilation. Intensive Care Medicine 2009;35:282-90.
21. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR et al. The pharmacokinetics of the new shortacting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79:881-92.
22. Hughes MA, Glass PS, Jacobs JR. Context-sensitive halftime in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-41.
23. Bonnet MP, Minville V, Asehnoune K, Bridoux D, Poggi-Bach J, Duranteau J et al. Glycine and ammonia plasma concentrations during sedation with remifentanil in critically ill patients. Intensive Care Med 2007;33:1179-82.
24. Morandi A, Watson PL, Trabucchi M, Ely EW. Advances in sedation for critically ill patients. Minerva Anestesiol 2009;75:385-91.
25. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974;2:656-9.
26. Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelly PT et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996;335:1864-9.
27. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/ North American multicenter study. JAMA 1993;270:2957-63.
28. Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology 2004;101:640-6.
29. Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001;95:324-33.
30. Kress JP, Pohlman AS, O'Connor AM, Hall J. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. New Engl J Med 2000;342:1471-78.
31. Al MJ, Hakkaart L, Tan SS, Bakker J. Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands. Crit Care 2010;14:R195.